PP
CVS icon

Paloma Partners’s CVS Health CVS Stock Holding History

Paloma Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,900
Closed -$644K – 1262
2024
Q2 		$644K Buy
+10,900
New +$682K 0.02% 645
2024
Q1 		– Sell
-11,100
Closed -$876K – 836
2023
Q4 		$876K Buy
11,100
+6,200
+127% +$441K 0.03% 442
2023
Q3 		$342K Buy
+4,900
New +$347K 0.01% 530
2023
Q2 		– Sell
-99,800
Closed -$7.42M – 792
2023
Q1 		$7.42M Buy
99,800
+86,200
+634% +$7.23M 0.26% 62
2022
Q4 		$1.27M Sell
13,600
-1,600
-11% -$154K 0.06% 313
2022
Q3 		$1.45M Buy
+15,200
New +$1.5M 0.07% 239
2019
Q4 		– Sell
-31,100
Closed -$1.96M – 2213
2019
Q3 		$1.96M Sell
31,100
-66,200
-68% -$3.92M 0.04% 438
2019
Q2 		$5.3M Buy
97,300
+13,200
+16% +$711K 0.09% 181
2019
Q1 		$4.54M Buy
84,100
+73,600
+701% +$4.54M 0.11% 192
2018
Q4 		$688K Sell
10,500
-13,300
-56% -$993K 0.02% 569
2018
Q3 		$1.87M Buy
23,800
+5,700
+31% +$408K 0.03% 481
2018
Q2 		$1.17M Sell
18,100
-57,400
-76% -$3.78M 0.02% 660
2018
Q1 		$4.7M Buy
75,500
+41,300
+121% +$2.96M 0.07% 224
2017
Q4 		$2.48M Buy
34,200
+10,000
+41% +$727K 0.03% 565
2017
Q3 		$1.97M Hold
24,200
– – 0.03% 755
2017
Q2 		$1.95M Sell
24,200
-152,600
-86% -$12M 0.02% 778
2017
Q1 		$13.9M Buy
+176,800
New +$14.1M 0.17% 84
2016
Q4 		– Sell
-16,000
Closed -$1.42M – 2002
2016
Q3 		$1.42M Sell
16,000
-16,000
-50% -$1.51M 0.02% 741
2016
Q2 		$3.06M Hold
32,000
– – 0.03% 458
2016
Q1 		$3.32M Buy
+32,000
New +$3.11M 0.05% 295

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Paloma Partners's CVS Position: Q3 2024 in Review

Paloma Partners sold out of CVS Health (CVS) in Q3 2024, closing a stake of 15,700 shares — an estimated $927K sold.

Paloma Partners first reported a position in CVS in Q2 2013 and held it in 38 quarters. The position peaked at $43.8M in Q1 2019. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Paloma Partners reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Paloma Partners sold 15,700 CVS Health shares in Q3 2024, an estimated $927K.
  • Paloma Partners first reported a position in CVS Health in Q2 2013 and held it in 38 quarters.
  • Paloma Partners's CVS Health position peaked at $43.8M in Q1 2019.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.